InDex Pharmaceuticals Holding Feed

Land	Sverige
Lista	First North Stockholm
Sektor	Hälsovård
Industri	Bioteknik

2019-10-09 18:00:00 Index Pharmaceuticals: Kommuniké från extra bolagsstämma i InDex Pharmaceuticals Holding AB (publ) +5,26% | 3,67 MSEK

2019-10-09 18:00:00 Index Pharmaceuticals: Bulletin from Extraordinary General Meeting in InDex Pharmaceuticals Holding AB (publ) +5,26% | 3,67 MSEK

2019-09-30 07:42:53 Index Pharmaceuticals: Redeye: InDex Pharmaceuticals - Vid ett vägskäl -8,15% | 10,7 MSEK

2019-09-19 23:10:00 Index Pharmaceuticals: InDex Pharmaceuticals Holding AB (publ) kallar till extra bolagsstämma +3,15% | 20,5 MSEK

2019-09-19 23:10:00 Index Pharmaceuticals: Notice of Extraordinary General Meeting in InDex Pharmaceuticals Holding AB (publ) +3,15% | 20,5 MSEK

2019-09-19 22:45:00 Index Pharmaceuticals: InDex Pharmaceuticals har genomfört en riktad nyemission av aktier om cirka SEK 140 miljoner (USD 14 miljoner) +3,15% | 20,5 MSEK

2019-09-19 22:45:00 Index Pharmaceuticals: InDex Pharmaceuticals has completed a directed share issue of approximately SEK 140 million (USD 14 million) +3,15% | 20,5 MSEK

2019-09-19 17:31:00 Index Pharmaceuticals: InDex Pharmaceuticals offentliggör avsikt att genomföra riktad nyemission av aktier +3,15% | 20,5 MSEK

2019-09-19 17:31:00 Index Pharmaceuticals: InDex Pharmaceuticals announces intention of a directed share issue +3,15% | 20,5 MSEK

2019-09-05 08:45:00 Index Pharmaceuticals: InDex Pharmaceuticals uppdaterar ägarlistan +0,52% | 16,0 MSEK

2019-09-05 08:45:00 Index Pharmaceuticals: InDex Pharmaceuticals updates shareholders list +0,52% | 16,0 MSEK

2019-08-27 07:00:00 Index Pharmaceuticals: InDex Pharmaceuticals meets primary endpoint in the phase IIb study CONDUCT with cobitolimod in ulcerative colitis +15,76% | 142 MSEK

2019-08-27 07:00:00 Index Pharmaceuticals: InDex Pharmaceuticals möter primära effektmåttet i fas IIb-studien CONDUCT med cobitolimod i ulcerös kolit +15,76% | 142 MSEK

2019-08-15 08:00:00 Index Pharmaceuticals: InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari - juni 2019 -1,71% | 4,01 MSEK

2019-08-15 08:00:00 Index Pharmaceuticals: InDex Pharmaceuticals Holding AB (publ) interim report January - June 2019 -1,71% | 4,01 MSEK

2019-06-26 15:50:00 Index Pharmaceuticals: InDex Pharmaceuticals får nytt patent i Europa +1,09% | 3,24 MSEK

2019-06-26 15:50:00 Index Pharmaceuticals: InDex Pharmaceuticals gets new patent in Europe +1,09% | 3,24 MSEK

2019-06-26 09:34:00 Index Pharmaceuticals: InDex Pharmaceuticals inkluderar sista patienten i fas IIb-studien CONDUCT med cobitolimod +1,09% | 3,24 MSEK

2019-06-26 09:34:00 Index Pharmaceuticals: InDex Pharmaceuticals enrolls last patient in phase IIb study CONDUCT with cobitolimod +1,09% | 3,24 MSEK

2019-06-03 08:00:00 Index Pharmaceuticals: InDex Pharmaceuticals presents at Redeye Growth Day on June 10, 2019 -2,68% | 0,50 MSEK

2019-06-03 08:00:00 Index Pharmaceuticals: InDex Pharmaceuticals presenterar på Redeye Growth Day, 10 juni 2019 -2,68% | 0,50 MSEK

2019-05-23 08:00:00 Index Pharmaceuticals: InDex Pharmaceuticals presenterar på Introduce Investor Days -2,18% | 0,36 MSEK

2019-05-23 08:00:00 Index Pharmaceuticals: InDex Pharmaceuticals presents at the Introduce Investor Days -2,18% | 0,36 MSEK

2019-05-06 19:00:00 Index Pharmaceuticals: Bulletin from Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) -1,00% | 0,41 MSEK

2019-05-06 19:00:00 Index Pharmaceuticals: Kommuniké från årsstämma i InDex Pharmaceuticals Holding AB (publ) -1,00% | 0,41 MSEK

2019-05-06 08:00:00 Index Pharmaceuticals: InDex Pharmaceuticals Holding AB (publ) interim report January - March 2019 +1,01% | 1,10 MSEK

2019-05-06 08:00:00 Index Pharmaceuticals: InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari - mars 2019 +1,01% | 1,10 MSEK

2019-04-11 20:00:00 Index Pharmaceuticals: InDex Pharmaceuticals ger statusuppdatering avseende patientrekryteringen i CONDUCT-studien -2,16% | 0,80 MSEK

2019-04-11 20:00:00 Index Pharmaceuticals: InDex Pharmaceuticals provides status update on the patient recruitment in the CONDUCT study -2,16% | 0,80 MSEK

2019-04-05 09:00:00 Index Pharmaceuticals: InDex Pharmaceuticals Holding AB (publ) kallar till årsstämma 0,00% | 0,10 MSEK

2019-04-05 09:00:00 Index Pharmaceuticals: Notice of Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) 0,00% | 0,10 MSEK

2019-04-02 17:30:00 Index Pharmaceuticals: InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2018 +0,24% | 0,55 MSEK

2019-04-02 17:30:00 Index Pharmaceuticals: InDex Pharmaceuticals Holding AB (publ) offentliggör årsredovisning för 2018 +0,24% | 0,55 MSEK

2019-03-26 07:39:13 Index Pharmaceuticals: Redeye: InDex Pharmaceuticals - Slutspurt i CONDUCT +4,34% | 1,20 MSEK

2019-02-20 08:00:00 Index Pharmaceuticals: InDex Pharmaceuticals Holding AB (publ) year end report 2018 +0,86% | 1,07 MSEK

2019-02-20 08:00:00 Index Pharmaceuticals: InDex Pharmaceuticals Holding AB (publ) bokslutskommuniké 2018 +0,86% | 1,07 MSEK

2018-11-19 14:00:00 InDex Pharmaceuticals presenterar på Redeye Life Science Day 21 november 2018 +5,80% | 0,47 MSEK

2018-11-19 08:00:00 InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari - september 2018 +5,80% | 0,47 MSEK

2018-11-19 08:00:00 InDex Pharmaceuticals Holding AB (publ) interim report January - September 2018 +5,80% | 0,47 MSEK

2018-11-06 12:00:00 InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2019 Annual General Meeting +5,26% | 0,14 MSEK

2018-11-06 12:00:00 InDex Pharmaceuticals Holding AB (publ) offentliggör valberedning inför årsstämman 2019 +5,26% | 0,14 MSEK

2018-10-23 21:00:00 InDex Pharmaceuticals genomför riktad nyemission om cirka 37,5 MSEK +3,61% | 0,43 MSEK

2018-10-23 21:00:00 InDex Pharmaceuticals carries out a directed share issue of approximately SEK 37.5 million +3,61% | 0,43 MSEK

2018-10-19 08:00:00 InDex Pharmaceuticals publicerar post-hoc analys av COLLECT-studien -2,99% | 0,09 MSEK

2018-10-19 08:00:00 InDex Pharmaceuticals publishes post-hoc analysis of the COLLECT study -2,99% | 0,09 MSEK

2018-08-28 08:00:00 InDex Pharmaceuticals Holding AB (publ) interim report January - June 2018 +2,72% | 0,41 MSEK

2018-08-28 08:00:00 InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari - juni 2018 +2,72% | 0,41 MSEK

2018-08-09 20:30:00 InDex Pharmaceuticals updates timeline for top line results from the CONDUCT study to first half of 2019 -15,46% | 3,13 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2019-11-27	Kvartalsrapport 2019-Q3
2019-10-09	Extra Bolagsstämma 2019
2019-08-22	Kvartalsrapport 2019-Q2
2019-08-15	Kvartalsrapport 2019-Q2
2019-05-07	Ordinarie utdelning INDEX 0.00 SEK
2019-05-06	Årsstämma 2018
2019-05-06	Kvartalsrapport 2019-Q1
2019-02-20	Bokslutskommuniké 2018
2018-11-19	Kvartalsrapport 2018-Q3
2018-08-28	Kvartalsrapport 2018-Q2
2018-05-25	Ordinarie utdelning INDEX 0.00 SEK
2018-05-24	Årsstämma 2017
2018-05-17	Kvartalsrapport 2018-Q1
2018-02-26	Bokslutskommuniké 2017
2017-11-17	Kvartalsrapport 2017-Q3
2017-08-25	Kvartalsrapport 2017-Q2
2017-05-31	Ordinarie utdelning INDEX 0.00 SEK
2017-05-30	Kvartalsrapport 2017-Q1
2017-05-30	Årsstämma 2016
2017-02-27	Bokslutskommuniké 2016
2016-11-22	Kvartalsrapport 2016-Q3

InDex Pharmaceuticals Holding

Beskrivning

Kalender

InDex Pharmaceuticals Holding

Beskrivning

Kalender

Språk

Typ

År

Språk

Typ

Företag

Pressmeddelanden